The dominance of central-line-associated bloodstream infection (CLABSI) prevention has become a powerful far-reaching endeavour in recent years. Surveillance is well established as an infection 'occurrence' reporting mechanism. Unfortunately, surveillance is rarely described in the literature as a component of CLABSI prevention. This changed in 2009 following the introduction of a preventative CLABSI surveillance initiative. Upon completion of the 2011 period of surveillance, the authors were able to demonstrate the insertion of 1012 catheters, which equalled 7522 line days and a 12-month period of zero CLABSI.